摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-tedanalactam | 1184869-42-8

中文名称
——
中文别名
——
英文名称
(+)-tedanalactam
英文别名
(3R,4R)-epoxy-2-piperidone;cis-3,4-Epoxypiperidin-2-one;(1R,6R)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
(+)-tedanalactam化学式
CAS
1184869-42-8
化学式
C5H7NO2
mdl
——
分子量
113.116
InChiKey
PHTVNQOAOFDDIK-QWWZWVQMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    41.6
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (+)-tedanalactam3-(3,4-dimethoxy-phenyl)-propionyl chloride正丁基锂 作用下, 以 四氢呋喃 为溶剂, 反应 6.67h, 以17 mg的产率得到(-)-piplaroxide
    参考文献:
    名称:
    Tedanalactam对映异构体的合成和(+)-Piplaroxide的第一个全合成和构型分配
    摘要:
    突显了最近建立的从叔烯丙基胺直接合成缩水甘油酰胺的方法,从相应的手性二氢哌啶中分两步完成了他那拉坦对映体的合成。另外,从它们各自的他达那他坦前体中获得了吡哌醇氧化物的(+)-和(-)-对映异构体,并确定了天然存在的(+)-吡哌醇氧化物的绝对构型。本方法不仅代表了最短的(-)-tedanalactam合成,而且代表了第一个总的(+)-piplaroxide合成,这是一种对切叶蚁Atta cephalotes的驱避剂。
    DOI:
    10.1021/acs.jnatprod.5b01041
  • 作为产物:
    描述:
    (1R,6R)-3-[(S)-1-(4-methoxyphenyl)ethyl]-7-oxa-3-azabicyclo-[4.1.0]heptan-2-one 在 ammonium cerium (IV) nitrate 作用下, 以 乙腈 为溶剂, 反应 4.0h, 以0.185 mg的产率得到(+)-tedanalactam
    参考文献:
    名称:
    Tedanalactam对映异构体的合成和(+)-Piplaroxide的第一个全合成和构型分配
    摘要:
    突显了最近建立的从叔烯丙基胺直接合成缩水甘油酰胺的方法,从相应的手性二氢哌啶中分两步完成了他那拉坦对映体的合成。另外,从它们各自的他达那他坦前体中获得了吡哌醇氧化物的(+)-和(-)-对映异构体,并确定了天然存在的(+)-吡哌醇氧化物的绝对构型。本方法不仅代表了最短的(-)-tedanalactam合成,而且代表了第一个总的(+)-piplaroxide合成,这是一种对切叶蚁Atta cephalotes的驱避剂。
    DOI:
    10.1021/acs.jnatprod.5b01041
点击查看最新优质反应信息

文献信息

  • Total Synthesis of (−)- and (+)-Tedanalactam
    作者:Mahesh S. Majik、Perunninakulath S. Parameswaran、Santosh G. Tilve
    DOI:10.1021/jo901143b
    日期:2009.8.21
    The first stereoselective route providing access to both enantiomers of tedanalactam. a naturally occurring piperidone, has been developed. The stereogenic centers were generated by the use of Sharpless asymmetric dihydroxylation. Tandem oxidation-Wittig reaction and one-pot deprotection, lactamization, and oxirane ring formation are the other key elements.
  • Synthesis of the Enantiomers of Tedanalactam and the First Total Synthesis and Configurational Assignment of (+)-Piplaroxide
    作者:Julio Romero-Ibañez、Leonardo Xochicale-Santana、Leticia Quintero、Lilia Fuentes、Fernando Sartillo-Piscil
    DOI:10.1021/acs.jnatprod.5b01041
    日期:2016.4.22
    established methodology for the direct synthesis of glycidic amides from tertiary allyl amines, the synthesis of the enantiomers of tedanalactam were completed in two steps from the corresponding chiral dihydropiperidine. Additionally, the (+)- and (−)-enantiomers of piplaroxide were obtained from their respective tedanalactam precursor, and the absolute configuration of the naturally occurring (+)-piplaroxide
    突显了最近建立的从叔烯丙基胺直接合成缩水甘油酰胺的方法,从相应的手性二氢哌啶中分两步完成了他那拉坦对映体的合成。另外,从它们各自的他达那他坦前体中获得了吡哌醇氧化物的(+)-和(-)-对映异构体,并确定了天然存在的(+)-吡哌醇氧化物的绝对构型。本方法不仅代表了最短的(-)-tedanalactam合成,而且代表了第一个总的(+)-piplaroxide合成,这是一种对切叶蚁Atta cephalotes的驱避剂。
查看更多

同类化合物

7-亚乙基-环戊二烯并(b)环氧乙烷并(c)吡啶六氢衍生物. 4-甲基-3-氧杂-6-氮杂三环[3.2.0.02,4]庚烷-7-酮 3-氧杂-6-氮杂三环[3.2.2.02,4]壬烷(8CI,9CI) 3-氧杂-1-氮杂三环[5.2.0.02,4]壬烷 2-氧杂-6-氮杂三环[4.3.1.01,3]癸烷 (1S,2R,4S,5R)-3-氧杂-6-氮杂三环[3.2.1.02,4]辛烷-7-酮 (5R,7S,8R,8aR)-5-dodecyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one (2S,2R,4S,5R,6S)-(+)-2-{2-[2-[1,3]-dioxolan-2-yl-ethyl]-6-methyl-4,5-epoxy-3,6-dihydro-2H-pyridin-1-yl}-2-phenylethanol (5R,7R,8S,8aR)-5-ethyl-7,8-epoxyoxazolidino[3,4-a]piperidine-3-one dihydroabikoviromycin (1R,6R)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-1-(hydroxymethyl)-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1aR,6aS,7R,7aS)-7-(t-butyldimethylsilyloxy)tetrahydro-1aH-oxazolo[3,4-a]oxireno[2,3-d]pyridin-4(2H)-one 11-formyl-(1rN,2tH,4tH,6cN,7tH,9tH)-3,8-dioxa-11-aza-tetracyclo[4.4.1.02,4.07,9]undecane 7-Oxa-2-azabicyclo[4.1.0]heptane (1S,6S)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-1-(hydroxymethyl)-3-[(1R)-2-hydroxy-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6S)-3-[(1R)-2-[tert-butyl(dimethyl)silyl]oxy-1-phenylethyl]-1-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-Oxa-10-azatricyclo[4.3.1.0~2,4~]decane (3S,5R,6R,7R)-6-hydroxy-4,9-dioxa-1-azatricyclo[5.3.0.03,5]decan-10-one (1RS,2SR,4RS,5SR)-3-oxa-6-azatricyclo[3.2.1.02,4]octan-7-one (1S,6S)-1-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-[(1S)-1-phenylethyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one 3-(methanesulfonyl)-7-oxa-3-azabicyclo[4.1.0]heptane 3α,4α-epoxy-2-piperidone (+)-tedanalactam 5-amino-1,2-anhydro-5-deoxy-D-lyxono-1,4-lactame (1R,5S,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,5R,6S)-5-((tert-butyldimethylsilyl)oxy)-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1S,6R)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6S)-4,4,6-trimethyl-7-oxa-3-azabicyclo[4.1.0]heptan-2-one (1R,6R)-3-(cyclopropylmethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-ethyl-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methylpropyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-(2-methoxyethyl)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6R)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,6S)-7-oxa-3-azabicyclo[4.1.0]heptane (1R,6S)-7-oxa-2-azabicyclo[4.1.0]heptane (1S,6R)-7-oxa-2-azabicyclo[4.1.0]heptane (1R,6R)-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2S,4R,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2R,4S,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1S,2S,4S,5R)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-4-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (2S,4R,7S)-3-oxa-1-azatricyclo[5.2.0.02,4]nonane (1R,6R)-1-methyl-3-propyl-7-oxa-3-azabicyclo[4.1.0]heptane (1S,2R,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1S,2S,4S,5S)-2-methyl-3-oxa-6-azatricyclo[3.2.0.02,4]heptan-7-one (1R,6S)-3-methyl-7-oxa-3-azabicyclo[4.1.0]heptane